Jay Strum is CSO at G1 Therapeutics, Inc. (GTHX). They have made 1 open-market trade across 1 company since 2018, most recently 2019-01-02.
CIK 0001706851
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GTHX | 129,237 | $924K |
Shares reported on the most recent Form 4, priced at the 2019-01-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GTHX | SELL | 2018-08-29 | 2018-08-31 | $59.60 | $596K | +12.7% | -14.9% | -34.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.